Nvidia bets on agentic AI to turbocharge biotech discovery
Nvidia's betting biotech's next breakthrough won't come from wet labs—it'll come from agents.
Why it matters
Nvidia is positioning agentic AI as a critical capability for accelerating drug discovery and biotech workflows. This signals where the chip giant sees AI's next high-value deployment opportunity beyond software—and what it's optimizing hardware for next.
The key facts
8 to knowNvidia VP Kimberly Powell spoke at Bio International Convention (largest biotech event)
Focus: agentic AI for biotech discovery acceleration
Nvidia messaging healthcare/life sciences as key vertical
Strategic positioning of agents as biotech workflow driver
Kimberly Powell (VP, Healthcare & Life Sciences at Nvidia) delivered keynote at Bio International Convention
Bio International Convention is largest biotech event with full ecosystem vendors
Event location: San Diego
Date: June 23, 2026
Go to the source
SiliconAnglesiliconangle.com
Publisher excerpt: Artificial intelligence played a prominent role at this week’s Bio International Convention in San Diego, the largest biotech event with vendors spanning the full ecosystem of companies in this industry. Today in a special address, Kimberly Powell (pictured), vice president and general manager of…